XML 32 R9.htm IDEA: XBRL DOCUMENT
v3.19.2

OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS | 6 Months Ended
--- | ---
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS | OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS Composition of Certain Financial Statement Captions Components of selected captions in the consolidated condensed balance sheets consisted of the following (in millions):
| June 30, 2019 |  | December 31, 2018
Inventories |  |  |
Raw materials | $ | 120.7 |  |  | $ | 111.5 |
Work in process | 164.4 |  |  | 144.8 |
Finished products | 339.8 |  |  | 350.7 |
| $ | 624.9 |  |  | $ | 607.0 |
At June 30, 2019 and December 31, 2018, $128.6 million and $106.5 million, respectively, of the Company's finished products inventories were held on consignment. During the three months ended June 30, 2019, the Company recorded a $46.2 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program.
| June 30, 2019 |  | December 31, 2018
Accounts payable and accrued liabilities |  |  |  |  |
Accounts payable | $ | 151.0 |  |  | $ | 134.0 |
Employee compensation and withholdings | 197.8 |  |  | 226.1 |
Taxes payable (Note 14) | 14.6 |  |  | 31.3 |
Property, payroll, and other taxes | 39.2 |  |  | 39.5 |
Research and development accruals | 55.8 |  |  | 48.9 |
Accrued rebates | 82.5 |  |  | 80.0 |
Fair value of derivatives | 4.6 |  |  | 4.4 |
Accrued marketing expenses | 15.5 |  |  | 22.3 |
Litigation and insurance reserves | 19.0 |  |  | 196.7 |
Accrued relocation costs | 13.0 |  |  | 11.3 |
Accrued professional services | 9.4 |  |  | 11.0 |
Accrued realignment reserves | 17.0 |  |  | 6.8 |
Other accrued liabilities | 53.8 |  |  | 64.3 |
| $ | 673.2 |  |  | $ | 876.6 |
Supplemental Cash Flow Information (in millions)
| Six Months Ended June 30,
| 2019 |  | 2018
Cash paid during the year for: |  |  |
Income taxes | $ | 45.2 |  |  | $ | 195.1 |
Amounts included in the measurement of lease liabilities: |  |  |
Operating cash flows from operating leases | $ | 12.7 |  |  | $ | — |
Non-cash investing and financing transactions: |  |  |  |  |
Fair value of shares issued in payment for contingent consideration liabilities | $ | — |  |  | $ | 34.3 |
Right-of-use assets obtained in exchange for new lease liabilities | $ | 23.5 |  |  | $ | — |
Capital expenditures accruals | $ | 21.8 |  |  | $ | 14.5 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration